Antisense Morpholino oligo starts phase III trial

1 post / 0 new
Jon Moulton
Jon Moulton's picture
Antisense Morpholino oligo starts phase III trial

Morpholino antisense oligo treating some Duchenne muscular dystrophy mutations (skipping dystrophin exon 51) starts phase III trial: http://clinicaltrials.gov/ct2/show/study/NCT02255552